Bottom line
Is RPNIX a good fund? The bottom line
RPNIX is the Institutional Class share class of Riverpark/Next Century Growth Fund, a managed large growth mutual fund from Riverpark.
Annual fees run 1.15% — about $115 a year on every $10,000 invested, more expensive than 74% of large growth funds we track.
It returned +7.7% over one year (as of Dec 31, 2025, per its prospectus).
With $12.1 million in net assets and 56 holdings, its largest position is Xometry, Inc. (4.4%) and the top 10 make up 32.5% of the portfolio.
What to watch
- Expensive for its category (1.15%)
- Small fund ($12.1 million) — small funds are likelier to close
Updated Nov 19, 2026
What RPNIX invests in
The RiverPark/Next Century Growth Fund (Next Century Growth or the Fund) seeks long-term capital appreciation through investments primarily in securities of small-cap companies.
The Fund, under normal market conditions, invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small cap companies. The Fund defines small cap companies as those with market capitalizations, at the time of initial investment, of less than the market capitalization of the largest company in the Russell 2000 Index on a rolling three-year basis. As of December 31, 2025, the market capitalization of the largest company in the Russell 2000 Index on a rolling three-year basis was $59.1 billion. The Fund seeks to achieve its investment objective by investing in companies that the Funds sub-adviser, Next Century Growth Investors, LLC (Next Century or the Sub-Adviser), believes will sustain above-average revenue and earnings growth over time, or which are expected to develop rapid sales and earnings growth in the future when compared to…
From the fund's prospectus (filed Feb 2, 2026).
RPNIX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RPNIX | +7.7% | — | — |
| Large Growth median | +15.2% | +11.0% | +14.2% |
Source: Fund prospectus, as of Dec 31, 2025
What RPNIX costs
On a $10,000 investment, RPNIX's 1.15% expense ratio costs about $115 a year. The prospectus estimates $1,842 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.
RPNIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Xometry, Inc. | 4.38% |
| 2 | Astronics Corporation | 3.58% |
| 3 | Ligand Pharmaceuticals Incorporated | 3.57% |
| 4 | Alignment Healthcare, Inc. | 3.52% |
| 5 | N/a | 3.24% |
| 6 | Knight-swift Transportation Holdings Inc. | 3.05% |
| 7 | Lincoln Educational Services Corporation | 3.02% |
| 8 | Mirum Pharmaceuticals, Inc. | 2.77% |
| 9 | Forgent Power Solutions, Inc. | 2.72% |
| 10 | Saia, Inc. | 2.64% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 32.5% of the fund. See all top 25 holdings and asset mix →